Pharma company to pay $95 million in settlement for 'off-label' drug promotion

Share this article:

A pharmaceutical company will pay $95 million over allegations of kickbacks regarding three medications used in skilled nursing facilities and hospitals.

Boehringer Ingelheim Pharmaceuticals manufactured the drugs: Aggrenox, used to prevent strokes; Combivent, used to treat Chronic Obstructive Pulmonary Disease; and Micardis, used to treat high blood pressure. The Department of Justice says Boehringer engaged in “off-label marketing” of the drugs.

The Food and Drug Administration has approved Aggrenox to prevent secondary strokes, Combivent to treat symptoms of bronchospasm in patients with COPD who already are on a bronchodilator, and Micardis to treat hypertension, the Department of Justice said.

The federal share of the civil settlement is more than $78 million; and the state Medicaid share is $16.5 million. The case was brought by a whistleblower in Maryland under the False Claims Act. That individual will receive $17 million from the federal share of the civil recovery.

The settlement reflects an increased interest of state and federal government in examining pharmaceutical companies and pharmacies distributing drugs for off-label use.

Share this article:

More in News

Nursing home administrators do not believe that pay-for-performance improves care quality or facility profitability, survey shows

Nursing home administrators do not believe that pay-for-performance ...

Most nursing home administrators do not believe that pay-for-performance initiatives lead to improved resident care or stronger bottom lines, according to findings recently published in the Journal of Aging and ...

Former CNA gets 16-year prison sentence for stealing nursing home residents' identities

Three former nursing home aides are facing prison time for stealing residents' identities and conning the government, state and federal authorities announced Thursday.

Aggression strongly signals pain only when dementia reaches advanced stages, researchers find

For a person with dementia, the link between aggressive behavior and physical pain is strong only in the condition's advanced stages, University of Florida researchers have found.